The Yale-DRC Clinical Metabolism Core provides comprehensive support for investigators conducting clinical investigations of human diseases of metabolism such as diabetes and obesity. The primary emphasis of this core is to provide analytical resources for patient-oriented studies utilizing stable isotopes to determine metabolic flux at the whole body and tissue specific levels. Secondarily, the core also makes its analytical resources available to researchers utilizing rat and cell models of human metabolic diseases. Stable isotopes offer unique advantages over traditional radioisotopic methods for assessing substrate turnover in humans as they do not expose subjects to ionizing radiation and they provide positional isotopomer information that can be used to assess flux through critical metabolic pathways. The major limitation to the use of stable isotopes by the clinical investigator is the need for sophisticated and expensive instrumentation and highly skilled expertise for instrument operation and for data analysis and interpretation The Yale-DRC Clinical Metabolism Core removes these obstacles by providing the personnel and resources needed for the extraction, purification, derivatization, and instrumental analysis needed to determine the concentrations and isotopic enrichments of metabolites in plasma, urine, or tissues. This core measures the isotopic (e.g., [2]H, [13]C, [5]N, and [18] 0) enrichment and concentrations of over 140 intermediary metabolites by GC-MS, LC-MS/MS, and NMR for the calculation of turnover of carbohydrates, lipids, and proteins. The primary purposes of the Yale-DRC Clinical Metabolism Core are to: 1) make GC-MS, LC-MS/MS, and NMR analyses available to DRC members, 2) avoid duplication of costs associated with personnel and instrumentation, 3.) provide standardized protocols to insure consistent and accurate sample analysis, and 4) assist Yale-DRC researchers in the design and interpretation of experiments utilizing stable isotopes for measurement of metabolic flux.

Public Health Relevance

The Yale-DRC Clinical Metabolism Core serves as a unique resource in providing both intramural and extramural researchers access to state-of-the-art analyses for measurements of stable, non radioactive, isotopes of metabolites obtained from patients with diabetes and other metabolic diseases, which in turn provides new insights into mechanism of disease and new therapies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK045735-22
Application #
8635338
Study Section
Special Emphasis Panel (ZDK1-GRB-S)
Project Start
Project End
Budget Start
2014-02-01
Budget End
2015-01-31
Support Year
22
Fiscal Year
2014
Total Cost
$159,828
Indirect Cost
$63,835
Name
Yale University
Department
Type
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Qiu, Yang; Perry, Rachel J; Camporez, João-Paulo G et al. (2018) In vivo studies on the mechanism of methylene cyclopropyl acetic acid and methylene cyclopropyl glycine-induced hypoglycemia. Biochem J 475:1063-1074
Perry, Rachel J; Peng, Liang; Cline, Gary W et al. (2018) Publisher Correction: Non-invasive assessment of hepatic mitochondrial metabolism by positional isotopomer NMR tracer analysis (PINTA). Nat Commun 9:498
Hu, Youjia; Peng, Jian; Li, Fangyong et al. (2018) Evaluation of different mucosal microbiota leads to gut microbiota-based prediction of type 1 diabetes in NOD mice. Sci Rep 8:15451
Belfort-DeAguiar, Renata; Seo, Dongju (2018) Food Cues and Obesity: Overpowering Hormones and Energy Balance Regulation. Curr Obes Rep 7:122-129
Dong, Rui; Zhu, Ting; Benedetti, Lorena et al. (2018) The inositol 5-phosphatase INPP5K participates in the fine control of ER organization. J Cell Biol 217:3577-3592
Bian, Xin; Saheki, Yasunori; De Camilli, Pietro (2018) Ca2+ releases E-Syt1 autoinhibition to couple ER-plasma membrane tethering with lipid transport. EMBO J 37:219-234
Jelenik, Tomas; Flögel, Ulrich; Álvarez-Hernández, Elisa et al. (2018) Insulin Resistance and Vulnerability to Cardiac Ischemia. Diabetes 67:2695-2702
Barentine, Andrew E S; Schroeder, Lena K; Graff, Michael et al. (2018) Simultaneously Measuring Image Features and Resolution in Live-Cell STED Images. Biophys J 115:951-956
Goedeke, Leigh; Bates, Jamie; Vatner, Daniel F et al. (2018) Acetyl-CoA Carboxylase Inhibition Reverses NAFLD and Hepatic Insulin Resistance but Promotes Hypertriglyceridemia in Rodents. Hepatology 68:2197-2211
Sherr, Jennifer L (2018) Closing the Loop on Managing Youth With Type 1 Diabetes: Children Are Not Just Small Adults. Diabetes Care 41:1572-1578

Showing the most recent 10 out of 620 publications